The Centers for Medicare and Medicaid Services recently announced negotiated prices for 15 drugs, finalizing the second iteration of the Medicare Drug Price Negotiation Program. The first set of negotiated drug prices will go into effect in January 2026.

Despite months of building the infrastructure and policies governing the program, stakeholders are unsure whether the implementation plan will deliver guaranteed access and adequate reimbursement for the negotiated drugs.

I spent the past year working on the Senate finance committee, which has oversight over CMS. After months of meetings with various industry groups and patient organizations, I am left with a feeling of amazement at the scale and scope of the negotiation program. I don’t think that even people who work in medicine unde

See Full Page